A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy ...
The VA has launched a trial to test Ozempic and Wegovy for alcohol use disorder in veterans.
People with alcohol use disorder taking oral semaglutide saw numerous improvements compared to placebo, a recent clinical ...
A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and ...
Glucagon-like peptide-1 (GLP-1) receptor agonist use is booming in the U.S., and it’s ushering in waves of reports of people ...
GLP-1 pill can reduce heavy drinking in adults who have a problem with alcohol, study finds - More than 27 million Americans ...
A dual GLP-1 and glucagon agonist developed by Altimmune has been shown to reduce drinking in people with alcohol use ...
More than 29.5 million Americans ages 12 and up had alcohol use disorder—the medical term for the disease commonly known as alcoholism—in 2022, when the most recent national data was published. The ...
Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking in a ...
The immune system is the body's protector. Following the detection of a potential threat, such as a bacterial or viral infection, a healthy immune system will attack the foreign invader. What many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results